Generics 192

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Artemether manufacturers

192 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

192 products found

artemether

Injection 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19722
This multinational pharmaceutical company focuses on improving global health through the development and manufacturing of a wide range of affordable pharmaceuticals and nutritional products. They specialize in producing tablets, capsules, pellets, soft gelatin capsules, and oral liquids. Key therapy areas include cardiovascular diseases, diabetes, and gastrointestinal disorders. They hold prominent GMP certifications, including ISO 9001:2015 and WHO GMP accreditations for facilities in multiple regions, including the EU, North America, and Asia. Their robust R&D department drives innovation, evident in their "Dispersion Technology" for enhanced drug absorption. The company actively participates in international conferences and sponsors research initiatives focused on combating priority diseases as identified by the World Health Organization.

artemether

Injection 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19540
This company is a pharmaceutical and nutraceutical manufacturer committed to ethical business practices and delivering high-quality products. They operate in both regulated and non-regulated markets, producing a range of Allopathic, Neutraceutical, Health food, and Pharmaceutical products. Their commitment to innovation and research drives the development of world-class formulations across key therapy areas. While specific product details and regions aren't provided, they emphasize adherence to Good Manufacturing Practices (GMP) and prioritize improving human healthcare through their products.

artemether + lumefantrine

Oral suspension 180 mg+1080 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19472
This company is a manufacturer and exporter of pharmaceutical products with over two decades of experience. They operate across three manufacturing facilities in India, specializing in a wide range of dosage forms including tablets, capsules, liquids, injectables, topicals, and nasal sprays. Their product portfolio encompasses generic, branded, nutraceutical, over-the-counter (OTC), and herbal medicines. Key therapy areas are not explicitly mentioned. They adhere to stringent quality standards with ISO 9001:2008 certification. The company exports its products to numerous regions globally, including the EU, North America, Africa, and the Middle East.

Want to see all 192 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Artemether is a medication used to treat malaria. Although manufacturers of artemether produce drugs with it as the standalone ingredient, it is almost always marketed in combination with lumefantrine. Artemether suppliers market it in the form of oral tablets as well as injectable solutions. The developer and earliest manufacturer of artemether/lumefantrine medications is Novartis, who markets it under the trade name Coartem. The standalone formulation was first introduced into medical use in 1987, whereas the artemether/lumefantrine combination formulation was first approved in 1992. Both drugs have since gained approvals in over 80 countries worldwide, including the U.S., China, numerous African countries and across Europe. What is more, the drug has become included in the World Health Organization’s list of Essential Medicines that contains the most important medications recommended for a basic health system. Alternatives to artemether are other artemisinin class malaria drugs such as dihydroartemisinin and artesunate. The prices of artemether medications are not particularly high. Its wholesale cost in the developing world typically falls into a range of 0,10 EUR to 1,00 EUR per daily treatment dose.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible